Swiss National Bank Zomedica Corp. Transaction History

Swiss National Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.2 - $0.34 $440,240 - $748,408	-2,201,200 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$0.28 - $0.4 $43,708 - $62,440	156,100 Added 7.63%	2,201,200 $742,000
Q3 2021 Nov 08, 2021	BUY	$0.46 - $0.81 $28,244 - $49,734	61,400 Added 3.1%	2,045,100 $1.07 Million
Q2 2021 Aug 06, 2021	BUY	$0.72 - $1.46 $1.43 Million - $2.9 Million	1,983,700 New	1,983,700 $1.65 Million

80.9M

Ticker ZOM
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 979,950,016
Market Cap $127M
Description
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.